Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Aug 2026 for Ultragenyx Pharmaceutical Inc., €101k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Howard Horn: trading record in brief
All filings by Howard Horn on record concern Ultragenyx Pharmaceutical Inc. The record holds 2 filings, for trades running from 1 July 2026 to 3 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 3 August 2026: a transaction of €101k, in Ultragenyx Pharmaceutical Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Howard Horn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,696 shares@ US$24.92CommonSEC144:0001950047-26-007510
4,698 shares@ US$33.130.0047% mcap100.0% of flowCommonSEC144:0001950047-26-006703
2 of 2 declarations
